Advertisement
Advertisement
U.S. markets open in 8 hours 44 minutes
Advertisement
Advertisement
Advertisement
Advertisement

TG Therapeutics, Inc. (TGTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
4.9900+0.0900 (+1.84%)
At close: 04:00PM EDT
4.9800 -0.01 (-0.20%)
After hours: 07:14PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Performance Outlook
Previous Close4.9000
Open4.8600
Bid0.0000 x 3200
Ask0.0000 x 4000
Day's Range4.7350 - 5.0200
52 Week Range4.7340 - 41.0000
Volume2,510,973
Avg. Volume2,565,688
Market Cap720.731M
Beta (5Y Monthly)2.24
PE Ratio (TTM)N/A
EPS (TTM)-2.4580
Earnings DateAug 01, 2022 - Aug 05, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.63
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TGTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • TG Therapeutics, Inc.
    Analyst Report: AbbVie IncAbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013. The company is based in suburban Chicago. The shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    22 hours agoArgus Research
View more
Advertisement
Advertisement